Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Red dots in the eye diagram indicate the cells with Ebola virus persistence in the vitreous humor and its immediately adjacent tissue of survivor eyes. Ebola virus genomic RNA in situ hybridization signal (red chromogen) was detected in a hematoxylin counterstained (blue in circle) eye section of rhesus monkey survivor. Fluorescent detection of Ebola virus replicative intermediate RNA (green fluorescence, red fluorescence is Ebola virus genomic RNA) by confocal microscope suggests Ebola virus replicates in the immune privileged sites. Credit: Xiankun Zeng and William Discher, U.S. Army Medical Research Institute of Infectious Diseases

Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. The study sheds light on how the virus persists in certain areas of the body, and holds promise for the development of medical products to counter the disease in humans.

During the 2013-2016 outbreak of Ebola in Western Africa, Ebola virus persistence in certain "immune privileged" sites—such as the eye, brain, and testes—became a significant concern. Survivors reported long-term effects such as loss of vision, headaches and joint pain, even after symptoms resolved. The virus also was shown to persist in seminal fluid and to have been transmitted through sexual intercourse. But until now, little was known about the mechanisms by which the virus entered these sites and escaped detection.

To begin to answer those questions, Xiankun Zeng, Ph.D. and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) analyzed archived tissues from that had previously been infected with Ebola virus to test experimental vaccines and treatments.

"In the animals that showed an acute, or shortened, course of disease, the virus primarily replicated in the blood vessels," Zeng explained. "In those with a longer disease progression, the virus spread to surrounding tissues in the immune privileged sites. And in the survivors, we could see that the virus had migrated out of the and into specific locations within immune privileged sites."

The USAMRIID team was able to demonstrate persistent Ebola virus replication in the eye, brain, and testes of animals that survived the disease and no longer had symptoms. The survivors consisted of two groups—those that had received medical countermeasures, and those that survived infection with only supportive care.

In the eye, the virus was found in macrophages that contain the protein CD68 in their surface, which could be where the virus "hides," according to the authors. They also showed that Ebola virus persists in the brain by breaking down the blood-brain barrier and causing inflammation.

"This study lays the foundation for developing animal models of persistent Ebola virus infection in humans," Zeng commented. "What we observed in primates is quite similar to what happened during the outbreak—there were survivors with latent infection, but the virus was not detectable in the blood. This makes it much more difficult to contain the spread of the virus."

In addition, the authors said, the study shows that otherwise promising experimental therapeutics may not clear the virus completely—suggesting that a different approach may be needed to develop medical countermeasures to Ebola virus.

According to Zeng, the next step is to further develop this animal model and to evaluate potential treatments, especially small-molecule therapeutics, to prevent Ebola virus persistence.

Explore further: Silence is golden—Suppressing host response to Ebola virus may help to control infection

More information: Xiankun Zeng et al, Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys, Nature Microbiology (2017). DOI: 10.1038/nmicrobiol.2017.113

Related Stories

Silence is golden—Suppressing host response to Ebola virus may help to control infection

March 22, 2017
The Ebola virus causes a severe, often fatal illness when it infects the human body. Initially targeting cells of the immune system called macrophages, white blood cells that absorb and clear away pathogens, a new study has ...

Responders to recent West Africa Ebola epidemic show little evidence of infection

May 16, 2017
Responders to the West African Ebola epidemic of 2014-2016 who returned to the UK and Ireland included many who reported possible Ebola virus exposure or Ebola-associated symptoms, according to a new study published in PLOS ...

Zika virus persists in the central nervous system and lymph nodes of rhesus monkeys

April 28, 2017
Zika virus can persist in cerebrospinal fluid (CSF), lymph nodes and colorectal tissue of infected rhesus monkeys for weeks after the virus has been cleared from blood, urine and mucosal secretions, according to a study published ...

Potential evidence of lung-specific Ebola infection found in recovering patient

January 5, 2017
Scientists have found potential evidence of Ebola virus replication in the lungs of a person recovering from infection, according to new research published in PLOS Pathogens. The findings could aid research into new treatment ...

Scientists gain better understanding of how Ebola disables people's immune defenses

May 24, 2017
University of Texas Medical Branch at Galveston scientists have unlocked mysteries of how the Ebola virus hampers the body's natural defenses to speed the rate of infection and its accompanying lethal disease, according to ...

Ebola survivors have a 'unique' retinal scar

May 15, 2017
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.